Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2005 1
2011 1
2012 1
2013 1
2014 2
2015 1
2016 4
2018 1
2019 4
2020 8
2021 6
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Evolving Best Practice for Take-Home Cancer Drugs.
Pardhan A, Vu K, Gallo-Hershberg D, Forbes L, Gavura S, Kukreti V. Pardhan A, et al. Among authors: gavura s. JCO Oncol Pract. 2021 Apr;17(4):e526-e536. doi: 10.1200/OP.20.00448. Epub 2020 Oct 20. JCO Oncol Pract. 2021. PMID: 33079644
Alternative Medicine and the Ethics Of Commerce.
Macdonald C, Gavura S. Macdonald C, et al. Among authors: gavura s. Bioethics. 2016 Feb;30(2):77-84. doi: 10.1111/bioe.12226. Bioethics. 2016. PMID: 26806450
Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer.
Arciero V, Luo J, Parmar A, Dai WF, Beca JM, Raphael MJ, Isaranuwatchai W, Habbous S, Tadrous M, Earle CC, Biagi JJ, Mittmann N, Arias J, Gavura S, Chan KKW. Arciero V, et al. Among authors: gavura s. JNCI Cancer Spectr. 2022 Jul 1;6(4):pkac047. doi: 10.1093/jncics/pkac047. JNCI Cancer Spectr. 2022. PMID: 35758620 Free PMC article.
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada.
Habbous S, Tai X, Beca JM, Arias J, Raphael MJ, Parmar A, Crespo A, Cheung MC, Eisen A, Eskander A, Singh S, Trudeau M, Gavura S, Dai WF, Irish J, Krzyzanowska M, Lapointe-Shaw L, Naipaul R, Peacock S, Yeung L, Forbes L, Chan KKW. Habbous S, et al. Among authors: gavura s. JAMA Netw Open. 2022 Aug 1;5(8):e2225118. doi: 10.1001/jamanetworkopen.2022.25118. JAMA Netw Open. 2022. PMID: 35917122 Free PMC article.
Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces.
Beca JM, Dai WF, Pataky RE, Tran D, Dvorani E, Isaranuwatchai W, Peacock S, Alvi R, Cheung WY, Earle CC, Gavura S, Chan KKW. Beca JM, et al. Among authors: gavura s. Clin Oncol (R Coll Radiol). 2022 Jan;34(1):e7-e17. doi: 10.1016/j.clon.2021.08.009. Epub 2021 Aug 26. Clin Oncol (R Coll Radiol). 2022. PMID: 34456106
Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall Survival.
Dai WF, Habbous S, Saluja R, Beca JM, Raphael M, Arias J, Gavura S, Earle CC, Biagi JJ, Coburn N, Chan KKW. Dai WF, et al. Among authors: gavura s. Clin Oncol (R Coll Radiol). 2023 May;35(5):e303-e311. doi: 10.1016/j.clon.2023.02.008. Epub 2023 Feb 16. Clin Oncol (R Coll Radiol). 2023. PMID: 36863956
Impact of rarity on Canadian oncology health technology assessment and funding.
Keech J, Dai WF, Trudeau M, Mercer RE, Naipaul R, Wright FC, Ferguson SE, Darling G, Gavura S, Eisen A, Kouroukis CT, Beca J, Chan KKW. Keech J, et al. Among authors: gavura s. Int J Technol Assess Health Care. 2020 Aug 11:1-6. doi: 10.1017/S0266462320000483. Online ahead of print. Int J Technol Assess Health Care. 2020. PMID: 32779560
31 results